Roche CEO warns on high pharma valuations By: CNBC.com News July 23, 2015 at 03:23 AM EDT Roche posted a 3 percent year-on-year rise in first-half sales, as demand for its oncology drugs helped offset the strength of the Swiss franc. Read More >> Related Stocks: Bristol-Myers Squibb Merck & Co Rogers Corp